Post-operative Thoracic Epidural Analgesia and Incidence of Major Complications: a Large Retrospective Dual Center Experi-ence

Sponsor
AHEPA University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05909007
Collaborator
Royal Brompton & Harefield NHS Foundation Trust (Other)
1,145
1
31
36.9

Study Details

Study Description

Brief Summary

A retrospective observational dual center study investigating side effects and major complications after thoracic epidural insertion according to local safety protocols.

Condition or Disease Intervention/Treatment Phase
  • Procedure: thoracic epidural insertion

Detailed Description

Abstract: (1) Background: Thoracic epidural analgesia is considered the gold standard in post-operative pain management following thoracic surgery. This study was designed to explore the safety of thoracic epidural analgesia and to quantify the incidence of its post-operative side-effects in patients undergoing thoracotomy for major surgery, such as resection of lung malignancies and lung transplantation. (2) Methods: This is a retrospective, dual-center observa-tional study implementing patients that underwent major thoracic surgery including lung trans-plantation and received concurrent placement of thoracic epidural catheters for postoperative an-algesia. An electronic system of referral and documentation of complications was used, and information was retrieved from our electronic critical care charting system. Side effects such as nausea and vomiting , itching, catheter related issues and also major complications such as epidural haematoma, abscess, or permanent nerve damage were investigated.

The study aims to highlight the importance of a solid documentation and recording system alongside with the implementation of safety protocols.

Study Design

Study Type:
Observational
Actual Enrollment :
1145 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Post-operative Thoracic Epidural Analgesia and Incidence of Major Complications: a Large Retrospective Dual Center Experi-ence
Actual Study Start Date :
Apr 1, 2012
Actual Primary Completion Date :
Nov 1, 2014
Actual Study Completion Date :
Nov 1, 2014

Outcome Measures

Primary Outcome Measures

  1. incidence of major complications [3 YEARS]

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes

Inclusion Criteria: 1. All patients undergoing major thoracic surgery ASA1-3 2. All patients undergoing lung transplantation

Exclusion Criteria: 1. Active bleeding 2. Coagulopathy 3. High inflammatory markers 4. SIRS 5. Lack of patients' consent for throracic epidural insertion

-

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ahepa University Hospital Thessaloniki Greece 54636

Sponsors and Collaborators

  • AHEPA University Hospital
  • Royal Brompton & Harefield NHS Foundation Trust

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
DESPOINA SARRIDOU, Assistant Professor of Anaesthesia, AHEPA University Hospital
ClinicalTrials.gov Identifier:
NCT05909007
Other Study ID Numbers:
  • 1111
First Posted:
Jun 18, 2023
Last Update Posted:
Jun 18, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 18, 2023